Editorial Comment from Dr Hatakeyama and Dr Ohyama to Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital‐Based Cancer Registry data in Japan
Editorial Comment from Dr Hatakeyama and Dr Ohyama to Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital‐Based Cancer Registry data in Japan
复制标题
Hatakeyama 博士和 Ohyama 博士对上尿路尿路上皮癌临床和病理 T 分期差异的编辑评论：日本医院癌症登记数据分析
DOI：
10.1111/iju.14593
复制
发表时间：
2021
影响因子：
2.6
通讯作者：
Ohyama Chikara
中科院分区：
文献类型：
--
作者：
Hatakeyama Shingo;Ohyama Chikara
上尿路尿路上皮癌（UTUC）患者准确的临床分期对于选择最佳治疗至关重要。 1 然而，在目前可用的成像模式下，根治性肾输尿管切除术前临床 T 分期的检测具有挑战性。 2 Shiga I 等人。 3 研究了 6831 名仅接受根治性肾输尿管切除术治疗的非转移性 UTUC (cT1-4N0M0) 患者的临床和病理 T 分期之间的差异。这项研究有两个重要发现：(i) 大约 30% 的 UTUC 患者出现分期上调，(ii) UTUC 中 cT3 分期准确率较高，但 cT2 分期准确率较低。作者表明，与 cT2 疾病患者（输尿管癌为 48.5%，肾盂癌为 33.3%）相比，cT3 疾病的 UTUC 患者具有更高的准确分期率（输尿管癌为 83.1%，肾盂癌为 80.2%）。 [摘自文章]International Journal of Urology 版权归 Wiley-Blackwell 所有，其内容不得复制或通过电子邮件发送未经版权所有者明确书面许可，发布到多个网站或发布到列表服务器。但是，用户可以打印、下载或通过电子邮件发送文章供个人使用。本摘要可能会被删节。不保证副本的准确性。用户应参阅该材料的原始发布版本以获取完整摘要。版权适用于所有摘要。
Accurate clinical staging of patients with upper urinary tract urothelial carcinoma (UTUC) is essential for the selection of optimal treatment. 1 However, the detection of clinical T stage before radical nephroureterectomy is challenging in the setting of the currently available imaging modalities. 2 Shiga I et al i. 3 investigated discrepancies between clinical and pathological T stages in patients with nonmetastatic UTUC (cT1-4N0M0) treated with radical nephroureterectomy alone in 6831 patients. This study had two important findings:(i) approximately 30% of UTUC patients had upstaging, and (ii) there was a higher rate of accurate cT3 staging, but a lower rate of accurate cT2 staging in UTUC. The authors showed that UTUC patients with cT3 disease had a higher accurate staging rate (83.1% in ureteral and 80.2% in renal pelvis cancers) compared to those with cT2 disease (48.5% in ureteral and 33.3% in renal pelvis cancers).[Extracted from the article]Copyright of International Journal of Urology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. Copyright applies to all Abstracts.
上尿路尿路上皮癌临床和病理 T 分期的差异：日本医院癌症登记数据分析
影响因子：
2.6
作者：
Masanobu Shiga;Y. Nagumo;I. Chihara;Satoshi Nitta;K. Kojo;T. Kimura;S. Kandori;T. Kojima;Ayako Okuyama;T. Higashi;H. Nishiyama
通讯作者：
H. Nishiyama